Regulus Therapeutics Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Regulus Therapeutics Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Regulus Therapeutics Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $93.1M.
  • Regulus Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $11.8M, a 163% increase from 2022.
  • Regulus Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4.49M, a 91.6% decline from 2021.
  • Regulus Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $53.7M, a 465% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.8M +$7.33M +163% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $4.49M -$49.2M -91.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $53.7M +$44.2M +465% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $9.51M -$30.4M -76.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $39.9M +$42.8M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 -$2.83M -$46.2M -107% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $43.4M +$22.9M +111% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $20.6M +$13.5M +193% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 $7.02M -$81.2M -92% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $88.2M +$41.8M +89.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
2013 $46.5M -$24M -34.1% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-23
2012 $70.5M +$70.8M Jan 1, 2012 Dec 31, 2012 10-K 2014-02-28
2011 -$354K -$15M -102% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-28
2010 $14.7M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.